Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: A cooperation task force (CTF) study

International Journal of Gynecological Cancer

Volumn 22, Issue 8, 2012, Pages 1355-1360

  Gadducci, Angiolo ^a   Cosio, Stefania ^a   Landoni, Fabio ^b   Maggino, Tiziano ^c   Zola, Paolo ^d   Fuso, Luca ^d   Sartori, Enrico ^e  

^a UNIVERSITY OF PISA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c Umberto i Hospital   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Chemotherapy; Pattern of failure; Radiotherapy; Surgical staging; Uterine papillary serous carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTICENTER STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84867281303     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318267f7a0     Document Type: Article

References (26)

1. Hendrickson M, Martinez A, Ross J, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;2:93-108.
2. Prat J, Gallardo A, Cuatrecasas M, et al. Endometrial carcinoma: pathology and genetics. Pathology. 2007;39:72-87.
3. Slomovitz BM, Burke TW, Eifel PJ. Uterine papillary serous carcinomas (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003;91:463-469.
4. Grice J, Ek M, Greer B, et al. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol. 1998;69:69-73.
5. KellyMG, O'Malley D, Hui P, et al. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecol Oncol. 2004;95:469-473.
6. Kelly MG, O'Malley DM, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005;98:353-359.
7. Chan JK, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003;90: 181-185.
8. Thomas MB, Mariani A, Cliby WA, et al. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;107: 186-189.
9. Roelofsen T, van Ham MA, de Hullu JA, et al. Clinical management of uterine papillary serous carcinoma. Expert Rev Anticancer Ther. 2011;11:71-81.
10. Rosenberg P, Blom R, Hogberg T, et al. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol. 1993;51:311-315.
11. Fader AN, Boruta D, Olawaiye AB, et al. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol. 2010;22:21-29.
12. Fader AN, Starks D, Gehrig PA, et al. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2009;115:244-248.
13. Kato DT, Ferry JA, Goodman A, et al. Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases. Gynecol Oncol. 1995;59:384-389.
14. Hui P, Kelly M, O'Malley DM, et al. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Mod Pathol. 2005;18:75-82.
15. Turner BC, Knisely JP, Kacinski BM, et al. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. Int J Radiat Oncol Biol Phys. 1998;40:77-84.
16. Boruta DM 2nd, Gehrig PA, Fader AN, et al. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol. 2009;115:142-153.
17. Huh WK, Powell M, Leath CA 3rd, et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003;91:470-475.
18. Bristow RE, Asrari F, Trimble EL, et al. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease. Gynecol Oncol. 2001;81:279-286.
19. FaderAN, DrakeRD, O'MalleyDM, et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 2009;115:2119-2127.
20. Obermair A, Mileshkin L, Bolz K, et al. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecol Oncol. 2011;120:179-184.
21. Sartori E, Pasinetti B, Chiudinelli F, et al. Surveillance procedures for patients treated for endometrial cancer: a reviewof the literature. Int J Gynecol Cancer. 2010;20:985-992.
22. Wyld D, Goh J, Nicklin JL, et al. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecol Oncol. 2011;120:179-184.
23. Bristow RE, Duska LR, Montz FJ. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Gynecol Oncol. 2001;81:92-99.
24. Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2006;24:36-44.
25. Fields AL, Einstein MH, Novetsky AP, et al. Pilot phase II trial of radiation ''sandwiched'' between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2008;108:201-206.
26. Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancerVresults from two randomised studies. Eur J Cancer. 2010;46:2422-2431.